Elicio Therapeutics
ELTX
ELTX
18 hedge funds and large institutions have $2.8M invested in Elicio Therapeutics in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
18
Holders Change
+3
Holders Change %
+20%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
6
Reduced
3
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$590K |
2 |
Millennium Management
New York
|
+$172K |
3 |
Citadel Advisors
Miami,
Florida
|
+$137K |
4 |
Geode Capital Management
Boston,
Massachusetts
|
+$31.3K |
5 |
MHC
Meyer Handelman Company
Rye Brook,
New York
|
+$5.59K |
Top Sellers
1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$549K |
2 |
UBS Group
Zurich,
Switzerland
|
-$5.31K |
3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.11K |